Progress towards achieving viral hepatitis B and C elimination in the Asia and Pacific region: Results from modelling and global reporting

In 2016, Asia and Pacific countries endorsed action plans for reaching viral hepatitis elimination targets set in the Global Health Sector Strategy (GHSS) for Viral Hepatitis 2016‐2021. We examine the region's progress by modelling disease burden and constructing the cascade of care. Between 20...

Full description

Saved in:
Bibliographic Details
Published in:Liver international 2022-08, Vol.42 (9), p.1930-1934
Main Authors: Le, Linh‐Vi, Blach, Sarah, Rewari, Bharat, Chan, Polin, Fuqiang, Cui, Ishikawa, Naoko, Sharma, Mukta, Mangadan‐Konath, Nabeel, Razavi, Homie, Low‐Beer, Daniel, Razavi‐Shearer, Devin
Format: Article
Language:English
Subjects:
Asia and Pacific
Chronic infection
elimination
Global health
HBV
HCV
Hepatitis
Hepatitis B
Hepatitis C
Hepatocellular carcinoma
Modelling
progress
Public health
viral hepatitis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In 2016, Asia and Pacific countries endorsed action plans for reaching viral hepatitis elimination targets set in the Global Health Sector Strategy (GHSS) for Viral Hepatitis 2016‐2021. We examine the region's progress by modelling disease burden and constructing the cascade of care. Between 2015 and 2020, chronic HBV prevalence declined from 4.69% to 4.30%, and HCV prevalence declined from 0.64% to 0.58%. The region achieved the 2020 target of 30% incidence reduction for HBV, whereas HCV incidence declined by 6%. Hepatocellular carcinoma incidence for HBV and HCV increased by 9% and 7%, respectively. Liver‐related deaths from HBV rose by 8%, and mortality attributable to HCV plateaued. Large testing and treatment gaps remained in 2019: only 13% of chronic HBV infections were diagnosed and 25% treated; 21% of chronic HCV infection were diagnosed and 11% treated. Viral hepatitis must become national priority with adequate funding to reach elimination goals by 2030.
ISSN:1478-3223
1478-3231
DOI:10.1111/liv.15131